These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38809380)

  • 1. Clinical Value of the Quantitative Flow Ratio to Predict Long-term Target Vessel Failure in Patients with In-stent Restenosis after Drug-coated Balloon Angioplasty.
    Wu XQ; Li LB; You W; Wu ZM; Zhao L; Wang ZH; Meng PN; Liu B; Ye F
    Curr Med Sci; 2024 Jun; 44(3):561-567. PubMed ID: 38809380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implication of quantitative flow ratio to predict clinical events after drug-coated balloon angioplasty in patients with in-stent restenosis.
    Tang J; Hou H; Chu J; Chen F; Yao Y; Gao Y; Ye Z; Zhuang S; Lai Y; Liu X
    Clin Cardiol; 2021 Jul; 44(7):978-986. PubMed ID: 34009672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
    Cai X; Tian F; Jing J; Jin Q; Zhou S; Yin W; Chen Y; Wu Q; Fu Z; Chen Y
    Catheter Cardiovasc Interv; 2021 May; 97 Suppl 2():1048-1054. PubMed ID: 33742738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study.
    Biscaglia S; Tebaldi M; Brugaletta S; Cerrato E; Erriquez A; Passarini G; Ielasi A; Spitaleri G; Di Girolamo D; Mezzapelle G; Geraci S; Manfrini M; Pavasini R; Barbato E; Campo G
    JACC Cardiovasc Interv; 2019 Oct; 12(20):2079-2088. PubMed ID: 31563688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cut-off values of lesion and vessel quantitative flow ratio in de novo coronary lesion post-drug-coated balloon therapy predicting vessel restenosis at mid-term follow-up.
    Meng PN; Liu B; Li LB; Yin DL; Zhang H; Pan DF; You W; Wu ZM; Wu XQ; Zhao L; Li ZB; Wang JP; Wang ZH; Xu T; Huang XY; Gao RN; Ye F
    Chin Med J (Engl); 2021 Jun; 134(12):1450-1456. PubMed ID: 34091522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease.
    Kogame N; Takahashi K; Tomaniak M; Chichareon P; Modolo R; Chang CC; Komiyama H; Katagiri Y; Asano T; Stables R; Fath-Ordoubadi F; Walsh S; Sabaté M; Davies JE; Piek JJ; van Geuns RJ; Reiber JHC; Banning AP; Escaned J; Farooq V; Serruys PW; Onuma Y
    JACC Cardiovasc Interv; 2019 Oct; 12(20):2064-2075. PubMed ID: 31563682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
    de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
    Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutoff Value and Long-Term Prediction of Clinical Events by FFR Measured Immediately After Implantation of a Drug-Eluting Stent in Patients With Coronary Artery Disease: 1- to 3-Year Results From the DKCRUSH VII Registry Study.
    Li SJ; Ge Z; Kan J; Zhang JJ; Ye F; Kwan TW; Santoso T; Yang S; Sheiban I; Qian XS; Tian NL; Rab TS; Tao L; Chen SL
    JACC Cardiovasc Interv; 2017 May; 10(10):986-995. PubMed ID: 28456699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery.
    Gitto M; Sticchi A; Chiarito M; Novelli L; Leone PP; Mincione G; Oliva A; Condello F; Rossi ML; Regazzoli D; Gasparini G; Cozzi O; Stefanini GG; Condorelli G; Reimers B; Mangieri A; Colombo A
    Circ Cardiovasc Interv; 2023 Dec; 16(12):e013232. PubMed ID: 37874646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of long-term adverse outcomes after successful chronic total occlusion intervention: physiology or morphology?
    Elbasha K; Alotaibi S; Heyer H; Mankerious N; Toelg R; Geist V; Richardt G; Allali A
    Clin Res Cardiol; 2024 Jul; 113(7):977-986. PubMed ID: 37542021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
    Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis.
    Wang X; Lu W; Wang X; Pan L; Fu W; Liu Q; Han Z; Sun G; Qin X; Li R; Zheng X; Shan Y; Qiu C
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):171-178. PubMed ID: 31919705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.
    Giacoppo D; Alvarez-Covarrubias HA; Koch T; Cassese S; Xhepa E; Kessler T; Wiebe J; Joner M; Hochholzer W; Laugwitz KL; Schunkert H; Kastrati A; Kufner S
    Eur Heart J; 2023 Apr; 44(15):1343-1357. PubMed ID: 36807512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-PCI CT-FFR Predicts Target Vessel Failure After Stent Implantation.
    Wang Z; Tang C; Zuo R; Zhou A; Xu W; Zhong J; Xu Z; Zhang L
    J Thorac Imaging; 2024 Jul; 39(4):232-240. PubMed ID: 38800956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implication of QFR in patients with ST-segment elevation myocardial infarction after drug-eluting stent implantation.
    Tang J; Chu J; Hou H; Lai Y; Tu S; Chen F; Yao Y; Ye Z; Gao Y; Mao Y; Zhuang S; Liu X
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):755-766. PubMed ID: 33044717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review.
    Xi Y; Chen J; Bi Y; Xie S; Liao T; Zhang Y; Kislauskis E; Wu T; Laham R; Xiao J
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E129-E141. PubMed ID: 31714010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-PCI quantitative flow ratio predicts 3-year outcome after rotational atherectomy in patients with heavily calcified lesions.
    You W; Zhou Y; Wu Z; Meng P; Pan D; Yin D; Yang S; Wu X; Ye F
    Clin Cardiol; 2022 May; 45(5):558-566. PubMed ID: 35312085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions.
    Kook H; Joo HJ; Park JH; Hong SJ; Yu CW; Lim DS
    BMC Cardiovasc Disord; 2020 Feb; 20(1):83. PubMed ID: 32070287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in patients treated with the zotarolimus-eluting stent at a tertiary medical center.
    Shammas NW; Shammas GA; Lemke J; Miller S; Meriner S
    J Invasive Cardiol; 2012 Jun; 24(6):256-60. PubMed ID: 22684377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of quantitative flow ratio after second-generation drug-eluting stent implantation to clinical outcomes.
    Suzuki N; Nishide S; Kimura T; Aoyagi T; Kanamori K; Shiratori Y; Hayami N; Murakawa Y; Kozuma K
    Heart Vessels; 2020 Jun; 35(6):743-749. PubMed ID: 31865431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.